*Executive Management Committee
- Global Management Structure
- EMC* Members
- Corporate Officers
Directors
Shoji HirashimaRepresentative DirectorSenior Executive OfficerHead of Japan Business Unit
Takashi f*ckuokaDirectorSenior Executive OfficerHead of Global Corporate StrategyCStO
Takashi MatsumotoDirectorExecutive OfficerHead of Global HR, CHRO
Kazuaki KamaOutside Director(Independent Director)Chairperson of the Board
Sawako NoharaOutside Director(Independent Director)Chairperson of the Compensation Committee
Yasuhiro KomatsuOutside Director(Independent Director)
Takaaki NishiiOutside Director(Independent Director)Chairperson of the Nomination Committee
Yo HonmaOutside Director(Independent Director)
Audit & Supervisory Board Members
Chief Executive Officer
Sunao Manabe
Chief Operating Officer
Hiroyuki Okuzawa
Global Corporate Function
Our seven global corporate functions, Global Corporate Strategy, Global Business Development, Global Corporate Planning & Management, Global DX, Global HR, Global Legal & IP and Global Compliance & Risk, support our CEO and COO in developing comprehensive and consistent corporate strategies and ensuring smooth management of the Daiichi Sankyo Group.
Takashi f*ckuokaHead of Global Corporate StrategyChief Strategy Officer
Takashi MatsumotoHead of Global HRChief Human Resources Officer (CHRO)
Naoki ShimizuHead of Global QAChief Quality Officer (CQO)
Business Units
Our six business units are responsible for strategic planning and execution in the regions of our business operations.
Oliver AppelhansHead of EU Specialty Business Unit
Kiminori NagaoHead of ASCA Business Unit
Takahiro UchidaHead of Daiichi Sankyo Healthcare Unit
Functional Units
Our four functional units, Research & Development, Technology, Quality Assurance & Regulatory Affairs, and Clinical Safety & Pharmacovigilance, help formulate and execute global strategies in their specialties. Each unit determines areas to be expanded globally, guides strategic planning and execution, and improves the efficiency of business operations.
Internal Audit
Terumichi YokoyamaHead of Global Internal Audit
Special Assignment
Koji OgawaDean, DS Academy
Shizuko UenoSpecial Assignment on Patient Centricity
Sunao ManabeCEOChair of the Committee
Hiroyuki OkuzawaCOO
Takashi f*ckuokaHead of Corporate StrategyCStO*1
Takashi MatsumotoHead of Global HRCHRO*2
Shoji HirashimaHead of Japan Business Unit
Hiroto KashiwaseHead of Technology Unit
Oliver Appelhans*4Head of EU Specialty Business Unit
Kiminori Nagao*4Head of ASCA Business Unit
Takahiro Uchida*4Head of Daiichi Sankyo Healthcare Unit
Naoki Shimizu*4Head of Global QACQO*7
Toshinori Agatsuma*4Head of Research
Shizuko Ueno*4Special Assignment on Patient Centricity
*1 CStO: Chief Strategy Officer
*2 CHRO: Chief Human Resources Officer
*3 GC: General Counsel
*4 EMC Extended Member
*5 CDXO: Chief Digital Transformation Officer
*6 CCO: Chief Compliance Officer
*7 CQO: Chief Quality Officer
Corporate Officers (Daiichi Sankyo Company, Limited)
| Name | Responsibilities |
|---|---|
| Sunao Manabe | Representative Director, Executive Chairperson & CEO |
| Hiroyuki Okuzawa | Representative Director, President & COO |
| Shoji Hirashima | Representative Director, Senior Executive Officer, Head of Japan Business Unit |
| Takashi f*ckuoka | Director, Senior Executive Officer, Head of Global Corporate Strategy, CStO*1 |
| Takashi Matsumoto | Director, Executive Officer, Head of Global HR, CHRO*2 |
| Hiroto Kashiwase | Executive Officer, Head of Technology Division |
| Koji Ogawa | Executive Officer, Head of Global Corporate Planning & Management, CFO |
| Nobuo Murakami | Executive Officer, Vice President of Corporate Strategy Department, Global Corporate Strategy |
| Shizuko Ueno | Executive Officer, Head of Medical Affairs Division, Japan Business Unit |
| Toshinori Agatsuma | Executive Officer, Head of R&D Division, Vice President of Research Function, R&D Division |
| Naoto Tsukaguchi | Corporate Officer, Head of Global Legal & IP, Vice President of Legal Affairs Department, GC*3 |
| Akio Sakurai | Corporate Officer, Head of Sales & Marketing Division, Japan Business Unit |
| Kiminori Nagao | Corporate Officer, Head of ASCA Business Division |
| Hiroshi Masumoto | Corporate Officer, Vice President of Data Intelligence Department, Global DX |
| Akihiro Inoguchi | Corporate Officer, Vice President of Development Function, R&D Division |
| Toshi Kajiro | Corporate Officer, Vice President of Technology Development Supervisory Department, Technology Division |
| Hiroya Senda | Corporate Officer, Vice President of Sales Planning Department, Sales & Marketing Division, Japan Business Unit |
| Satoru Ogawa | Corporate Officer, Vice President of Secretariat Department |
| Atsushi Tsukamoto | Corporate Officer, Head of Therapeutic Area Strategies, Research & Development Unit, Daiichi Sankyo, Inc. |
| Tetsuya Iwabuchi | Corporate Officer, In charge of Business Development |
| Koji Sato | Corporate Officer, Head of Project Lead & DSI Technology Unit, Technology Unit, Daiichi Sankyo, Inc. |
| Tetsuya Ohira | Corporate Officer, Vice President of Corporate Planning Department, Global Corporate Planning & Management |
| Koichi Nonaka | Corporate Officer, Vice President of Technology Development & Management Department, Technology Development Supervisory Department, Technology Division |
| Hanako Saito | Corporate Officer, In charge of QA and CSPV*4 |
| Kenji Shigeta | Corporate Officer, Head of Global Oncology Marketing, Oncology Business Unit, Daiichi Sankyo, Inc |
| Akihiro Tokumoto | Corporate Officer, Vice President of Human Resources Department, Global HR |
| Junichi Ashihara | Corporate Officer, Vice President of Japan Plant Management Supervisory Department, Technology Division |
| Hideaki Noji | Corporate Officer, Vice President of Business Management Department, Japan Business Unit |
| Yuki Abe | Corporate Officer, Vice President of Research Innovation Planning Department, Research Function, R&D Division |
*1 CStO: Chief Strategy Officer
*2 CHRO: Chief Human Resources Officer
*3 GC: General Counsel
*4 QA: Quality Assurance; CSPV: Clinical Safety & Pharmacovigilance
